Botulinum Toxin Products Display Warnings, Receive Name Changes | OphthalmologyWeb: The Ultimate Online Resource for Ophthalmologists

Friday, August 21, 2009

Email

Comments

Ophthalmology Times

The FDA announced that four botulinum toxin drug products now have boxed warnings on their labels and include medication guides that explain the risk of adverse events to patients, as directed by the agency in April.

Which of the following is true regarding aqueous formation?
1. It is independent of intraocular pressure
2. It is formed at the rate of 2 -3 ml per minute
3. It is the result of secretion
4. It is the result of filtration
5. Both C and D
Check The Answer

PanoCam™ LT Wide-field Digital Imaging System
The PanoCam LT represents the first ... view product
OPMI LUMERA 700 Surgical Microscope
OPMI LUMERA 700 Incorporating the latest... view product

View all Featured Products »

Keep up with our latest articles, news and events. Plus, get special offers and more delivered to your inbox.

Like us
on Facebook Follow us
on Twitter

OphthalmologyWeb wants to hear from you. Submit your case studies, clinical pearls, practice management tips, editorial, or other manuscripts.

Learn more about writing for us